News & Events :: Algernon Pharmaceuticals Inc. (AGN)

Recent News View All News

Nov 16, 2022 7:00am EST

Algernon Pharmaceuticals Screens First Subject in Phase 1 DMT Human Stroke Study

Oct 24, 2022 7:00am EDT

Algernon Pharmaceuticals Enters into a Clinical Trial Agreement with Yale University for a DMT Phase 2 Depression Study

Recent Events View IR Calendar

Nov 3 – Nov 5, 2022

2022 Wonderland Psychedelic Conference

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals is a clinical stage pharmaceutical development company.

Sign up for our News Releases and Updates

Head Office

Suite 400 - 601 West Broadway
Vancouver, British Columbia V5Z 4C2

Follow Us On

© Algernon Pharmaceuticals Inc. - All Rights Reserved